A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bc Cancer Vancouver
Vancouver, British Columbia, Canada
Recruiting - Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Recruiting
- Local Institution - 0006
Badalona, Barcelona [Barcelona], Spain
Not, yet, recruiting - Local Institution - 0008
Hortaleza, Madrid, Spain
Not, yet, recruiting
- Johns Hopkins Hospital
Baltimore, Maryland, United States
Recruiting - Next Oncology
San Antonio, Texas, United States
Recruiting - Start Mountain Region
West Valley City, Utah, United States
Recruiting - Next Virginia
Fairfax, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Nov 2025
- Primary completion
- 13 Oct 2028
- Completion
- 13 Oct 2028
- Last update posted
- 28 May 2026
- Registered enrollment
- 252
- Registry id
- NCT07223047
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.